Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

34
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
34
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

69
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
69
Antimicrobial Proteins01:23

Antimicrobial Proteins

15.4K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.4K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

46
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
46

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

S. aureus infections in hospitalized children with hematological, hepatological or kidney diseases over a 16-year period at a tertiary care hospital in Sweden: a retrospective observational study.

Italian journal of pediatrics·2026
Same author

Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Identification of immunostimulatory antigens in Group A <i><i>Streptococcus</i></i>-derived vesicles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Closing the Stable Door on Strangles: Serological Responses of Vaccinated Horses on a Farm Following the Arrival of a New Horse.

Animals : an open access journal from MDPI·2025
Same author

Reining in strangles: Absence of disease in horses vaccinated with a DIVA-compatible recombinant fusion protein vaccine, Strangvac, following natural exposure to Streptococcus equi subspecies equi.

Equine veterinary journal·2025
Same author

Neutralisation of the Immunoglobulin-Cleaving Activity of <i>Streptococcus equi</i> Subspecies <i>equi</i> IdeE by Blood Sera from Ponies Vaccinated with a Multicomponent Protein Vaccine.

Vaccines·2025

Related Experiment Video

Updated: Mar 31, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K

Streptococcal M1 Strikes by Neutralizing Cathelicidins.

Birgitta Henriques-Normark1, Staffan Normark1

  • 1Department of Microbiology, Cell Biology and Tumorbiology, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Cell Host & Microbe
|October 16, 2015
PubMed
Summary
This summary is machine-generated.

Hypervirulent group A streptococci use M1 protein to evade the human antimicrobial peptide cathelicidin. This finding reveals a new mechanism for bacterial virulence and potential therapeutic targets.

More Related Videos

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

11.5K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

14.2K

Related Experiment Videos

Last Updated: Mar 31, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K
Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

11.5K
Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
06:05

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins

Published on: September 30, 2014

14.2K

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Group A Streptococcus (GAS) infections pose a significant public health threat.
  • The emergence of hypervirulent M1T1 lineage has increased GAS pathogenicity.
  • Antimicrobial peptides are crucial components of the innate immune system.

Purpose of the Study:

  • To investigate the role of the streptococcal M1 protein in host-pathogen interactions.
  • To determine how hypervirulent GAS evades host immune defenses.
  • To identify mechanisms by which GAS M1 protein contributes to virulence.

Main Methods:

  • The study utilized biochemical assays to analyze the interaction between M1 protein and cathelicidin.
  • Bacterial strains and purified proteins were employed to mimic infection conditions.
  • Functional assays were performed to assess the impact of M1 protein on antimicrobial activity.

Main Results:

  • The streptococcal M1 protein was found to directly bind and neutralize the human antimicrobial peptide cathelicidin.
  • This neutralization prevents cathelicidin from effectively killing GAS bacteria.
  • M1 protein's ability to inhibit cathelicidin contributes to the virulence of the M1T1 lineage.

Conclusions:

  • The M1 protein of group A Streptococcus is a virulence factor that subverts innate immunity.
  • Neutralization of cathelicidin by M1 protein is a key mechanism enabling hypervirulent GAS survival and infection.
  • Targeting this interaction could offer novel therapeutic strategies against severe streptococcal diseases.